These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 25662948)

  • 1. Milestones in Friedreich ataxia: more than a century and still learning.
    Abrahão A; Pedroso JL; Braga-Neto P; Bor-Seng-Shu E; de Carvalho Aguiar P; Barsottini OG
    Neurogenetics; 2015 Jul; 16(3):151-60. PubMed ID: 25662948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Friedreich ataxia: an update on animal models, frataxin function and therapies.
    González-Cabo P; Llorens JV; Palau F; Moltó MD
    Adv Exp Med Biol; 2009; 652():247-61. PubMed ID: 20225031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
    Anjomani Virmouni S; Ezzatizadeh V; Sandi C; Sandi M; Al-Mahdawi S; Chutake Y; Pook MA
    Dis Model Mech; 2015 Mar; 8(3):225-35. PubMed ID: 25681319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Friedreich ataxia: the clinical picture.
    Pandolfo M
    J Neurol; 2009 Mar; 256 Suppl 1():3-8. PubMed ID: 19283344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.
    Evans-Galea MV; Lockhart PJ; Galea CA; Hannan AJ; Delatycki MB
    Discov Med; 2014 Jan; 17(91):25-35. PubMed ID: 24411698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia.
    Simon D; Seznec H; Gansmuller A; Carelle N; Weber P; Metzger D; Rustin P; Koenig M; Puccio H
    J Neurosci; 2004 Feb; 24(8):1987-95. PubMed ID: 14985441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules affecting transcription in Friedreich ataxia.
    Gottesfeld JM
    Pharmacol Ther; 2007 Nov; 116(2):236-48. PubMed ID: 17826840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-based approaches toward Friedreich ataxia therapeutics.
    Hebert MD; Whittom AA
    Cell Mol Life Sci; 2007 Dec; 64(23):3034-43. PubMed ID: 17828464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
    Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
    J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.
    Li H; Gakh O; Smith DY; Ranatunga WK; Isaya G
    J Biol Chem; 2013 Feb; 288(6):4116-27. PubMed ID: 23269675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Friedreich Ataxia: From the Eye of a Molecular Biologist.
    Muthuswamy S; Agarwal S
    Neurologist; 2015 Sep; 20(3):51-5. PubMed ID: 26375377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells.
    Lee YK; Ho PW; Schick R; Lau YM; Lai WH; Zhou T; Li Y; Ng KM; Ho SL; Esteban MA; Binah O; Tse HF; Siu CW
    Pflugers Arch; 2014 Sep; 466(9):1831-44. PubMed ID: 24327207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus.
    Al-Mahdawi S; Sandi C; Mouro Pinto R; Pook MA
    PLoS One; 2013; 8(9):e74956. PubMed ID: 24023969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Regulation of the Disease-Causing Gene
    Dong YN; Mercado-Ayón E; Coulman J; Flatley L; Ngaba LV; Adeshina MW; Lynch DR
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinical investigation of Iranian patients with Friedreich ataxia.
    Salehi MH; Houshmand M; Aryani O; Kamalidehghan B; Khalili E
    Iran Biomed J; 2014; 18(1):28-33. PubMed ID: 24375160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered nucleosome positioning at the transcription start site and deficient transcriptional initiation in Friedreich ataxia.
    Chutake YK; Costello WN; Lam C; Bidichandani SI
    J Biol Chem; 2014 May; 289(22):15194-202. PubMed ID: 24737321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts.
    Khonsari H; Schneider M; Al-Mahdawi S; Chianea YG; Themis M; Parris C; Pook MA; Themis M
    Gene Ther; 2016 Dec; 23(12):846-856. PubMed ID: 27518705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterising the neuropathology and neurobehavioural phenotype in Friedreich ataxia: a systematic review.
    Corben LA; Georgiou-Karistianis N; Bradshaw JL; Evans-Galea MV; Churchyard AJ; Delatycki MB
    Adv Exp Med Biol; 2012; 769():169-84. PubMed ID: 23560311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
    Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
    Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Friedreich's ataxia: from disease mechanisms to therapeutic interventions.
    Lodi R; Tonon C; Calabrese V; Schapira AH
    Antioxid Redox Signal; 2006; 8(3-4):438-43. PubMed ID: 16677089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.